As of 2024-12-13, the Relative Valuation of Karyopharm Therapeutics Inc (KPTI) is (10.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.72 USD, the upside of Karyopharm Therapeutics Inc based on Relative Valuation is -1599.4%.
The range of the Relative Valuation is (11.25) - (13.91) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.1x - 21.0x | 11.9x |
| Forward P/E multiples | 16.1x - 19.9x | 19.2x |
| Fair Price | (11.25) - (13.91) | (10.86) |
| Upside | -1654.3% - -2020.7% | -1599.4% |
| Date | P/E |
| 2024-12-10 | -1.05 |
| 2024-12-09 | -1.11 |
| 2024-12-06 | -1.10 |
| 2024-12-05 | -1.14 |
| 2024-12-04 | -1.14 |
| 2024-12-03 | -1.16 |
| 2024-12-02 | -1.18 |
| 2024-11-29 | -1.21 |
| 2024-11-27 | -1.22 |
| 2024-11-26 | -1.25 |
| 2024-11-25 | -1.20 |
| 2024-11-22 | -1.21 |
| 2024-11-21 | -1.11 |
| 2024-11-20 | -1.11 |
| 2024-11-19 | -1.11 |
| 2024-11-18 | -1.14 |
| 2024-11-15 | -1.17 |
| 2024-11-14 | -1.20 |
| 2024-11-13 | -1.24 |
| 2024-11-12 | -1.29 |
| 2024-11-11 | -1.32 |
| 2024-11-08 | -1.26 |
| 2024-11-07 | -1.26 |
| 2024-11-06 | -1.27 |
| 2024-11-05 | -1.21 |
| 2024-11-04 | -1.34 |
| 2024-11-01 | -1.29 |
| 2024-10-31 | -1.42 |
| 2024-10-30 | -1.20 |
| 2024-10-29 | -1.21 |
| 2024-10-28 | -1.29 |
| 2024-10-25 | -1.18 |
| 2024-10-24 | -1.17 |
| 2024-10-23 | -1.22 |
| 2024-10-22 | -1.22 |
| 2024-10-21 | -1.22 |
| 2024-10-18 | -1.25 |
| 2024-10-17 | -1.22 |
| 2024-10-16 | -1.21 |
| 2024-10-15 | -1.20 |
| 2024-10-14 | -1.22 |
| 2024-10-11 | -1.23 |
| 2024-10-10 | -1.21 |
| 2024-10-09 | -1.22 |
| 2024-10-08 | -1.21 |
| 2024-10-07 | -1.25 |
| 2024-10-04 | -1.27 |
| 2024-10-03 | -1.26 |
| 2024-10-02 | -1.27 |
| 2024-10-01 | -1.08 |